MARGINAL ZONE LYMPHOMA(MZL)
Clinical trials for MARGINAL ZONE LYMPHOMA(MZL) explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE LYMPHOMA(MZL) trials appear
Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA(MZL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare eye cancer: drug combo trial shows promise
Disease control OngoingThis study tests a new drug (orelabrutinib) combined with either low-dose radiation or another drug (rituximab) for a rare type of eye lymphoma called ocular adnexal MALT lymphoma. About 39 adults with early-stage disease who haven't had prior treatment will participate. The goal…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
New antibody therapy shows promise for Tough-to-Treat lymphomas
Disease control OngoingThis study tests a new drug called epcoritamab (GEN3013) in people with B-cell lymphoma that has come back or stopped responding to treatment. The drug is an antibody that helps the immune system attack cancer cells. The trial aims to find the best dose, check for side effects, a…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New combo therapy aims to wipe out lymphoma without prior treatment
Disease control OngoingThis study tests a combination of three drugs (orelabrutinib, zuberitamab, and chemotherapy) in 65 adults with untreated marginal zone lymphoma, a slow-growing blood cancer. The goal is to see if the treatment can make all signs of cancer disappear and keep it away for at least 2…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
Is 'Watch and Wait' really 'Worry and Wait'? new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how the 'watch and wait' approach affects the quality of life of people with slow-growing lymphomas. Researchers want to know if waiting without treatment causes anxiety or worry. About 250 Korean adults with these cancers will fill out questionnaires to measu…
Matched conditions: MARGINAL ZONE LYMPHOMA(MZL)
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:11 UTC